Preventice Solutions announced today that it appointed former Medtronic executive Tom Sheehy as its new executive vice president and chief commercial officer, effective immediately. Sheehy previously served as a senior area sales director for the diagnostics and coronary sales team at medtech giant Medtronic (NYSE:MDT). He also held a national sales leadership role, integrating TYRX antibiotic […]
Medtronic
4 medical device industry trends affecting innovation
Major medical device companies are increasingly outsourcing their innovation. Here’s what that means. The medical device industry is increasingly relying on small, young companies to provide innovations, but the early-stage medtech companies are mostly relying on angel investors. It’s also more important than ever to protect intellectual property and mitigate exposure to litigation. Those were […]
Indiana man may proceed with pain pump lawsuit against Medtronic
An Indiana federal judge on Friday dismissed two parts of a lawsuit against Medtronic (NYSE:MDT), but said that the plaintiff can continue to pursue the third count. Kirk Bledsoe sued Medtronic in Indiana state court in 2017 after the company’s Synchromed II pain pump, which Bledsoe had implanted in 2011, failed on two occasions and […]
The 10 greatest medtech advances of the 2010s
From disposable endoscopes to TAVR to robotic surgery, there’s a whole host of medtech advances widely available now that weren’t around much 10 years ago. “In terms of technological advances, I would put this past decade as one of the most important for medical technology. From connected devices and robotics, to advances in material sciences […]
10 medical device industry stories you need to know
From leadership changes to tax repeal to robots — lots of robots — this was a busy year for the medical device industry. Here are 10 stories in the medtech space that especially caught the eye of MassDevice and Medical Design & Outsourcing editors and readers in 2019. Next>>
Report: FDA has nonpublic list of TAVR-related deaths
The FDA has yet another private listing of device-related deaths, this one for transcatheter aortic valve replacement (TAVR) devices that include Medtronic’s (NYSE:MDT) CoreValve and Edwards Lifesciences’ (NYSE:EW) Sapien 3 lines, according to a new report by Kaiser Health News. Both devices were initially indicated for patients who were too frail or ill for open-heart surgery, but the FDA subsequently approved […]
Medtronic wins dismissal of Pennsylvania couple’s DBS lawsuit
Medtronic has prevailed in a personal injury lawsuit over a deep-brain stimulation implant approved by the FDA to treat neurological disorders. A federal judge in Philadelphia on Monday granted the company’s motion to dismiss the lawsuit filed by Edward Walls and his wife, Tonya Chavis-Walls. The couple had claimed in Pennsylvania state court that two […]
Medtronic wins FDA clearance for brain surgery guidance system
Medtronic (NYSE:MDT) today said it won FDA clearance for its cranial robotic platform the Stealth Autoguide system. The Stealth Autoguide Platform is a robotic guidance system that is designed for spatial positioning and orientation of instrument holders and tool guides that are used in neurosurgical procedures. “Medtronic continues to deliver on its commitment of developing innovative […]
Medtronic adds an AI Klue to its diabetes management lineup
Medtronic (NYSE:MDT) said today it has completed the acquisition of Klue, a San Jose, Calif.-based software company that tracks people’s eating in real-time and analyzes it with artificial intelligence (AI) to help control diabetes. Medtronic plans to incorporate Klue’s technology into its Personalized Closed Loop (PCL) insulin pump system, which won FDA breakthrough device designation in February. PCL is […]
Medtronic pain pump recall deemed Class I
The FDA has classified the recall of Medtronic’s (NYSE:MDT) SynchroMed II implantable drug pumps as Class I, the most serious type of recall. The company announced the voluntary recall in October, saying that it had received complaints about the pumps’ motors stalling permanently. Permanent motor stall could prevent the infusion of drugs to the patient, […]
Axonics raises additional $17m in public offering
Sacral neuromodulation device-maker Axonics Modulation Technologies (NSDQ:AXNX) announced that the underwriters of its follow-on public offering exercised in full their option to buy an additional 750,000 shares of common stock. The additional shares are set to be purchased from Axonics at the offering price of $22 per share, less underwriting discounts and commissions, according to a news […]